FDCDDQ
CPRX

Federation des caisses Desjardins du Quebec’s Catalyst Pharmaceutical CPRX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.15K Buy
+167
New +$3.98K ﹤0.01% 2544
2023
Q4 		– Sell
-42
Closed -$491 – 2390
2023
Q3 		$491 Sell
42
-148
-78% -$1.98K ﹤0.01% 2209
2023
Q2 		$2.55K Buy
+190
New +$2.73K ﹤0.01% 2029

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Federation des caisses Desjardins du Quebec's CPRX Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec opened a new position in Catalyst Pharmaceutical (CPRX) in Q1 2026: 167 shares worth $4.15K. The stake represents ﹤0.01% of the portfolio and ranks #2544 among its holdings. This is a return to the name: Federation des caisses Desjardins du Quebec previously reported a position in CPRX as recently as Q3 2023.

Federation des caisses Desjardins du Quebec first reported a position in CPRX in Q2 2023 and has held it in 3 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Federation des caisses Desjardins du Quebec held 167 shares of Catalyst Pharmaceutical worth $4.15K as of Q1 2026.
  • Catalyst Pharmaceutical was a new Federation des caisses Desjardins du Quebec position in Q1 2026.
  • Catalyst Pharmaceutical made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #2544 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Catalyst Pharmaceutical in Q2 2023 and has held it in 3 quarters since.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.